{"article": [{"url": "https://stocknews.com/news/fgen-fibrogen-fgen-nears-a-support-level/", "published": 1598443700.0, "headline": "Chart Analysis: FibroGen (FGEN) Nears a Support Level", "body": "Over the past couple of months a key support level was formed in the chart of FibroGen Inc. (FGEN). FGEN is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company recently announced the initiation of LELANTOS, a Phase 3 trial of pamrevlumab in combination with systemic corticosteroids in patients with non-ambulatory Duchenne muscular dystrophy. Take a look at the 1-year chart of FGEN with added notations: 7 Best ETFs for the NEXT Bull Market (Chart of FGEN provided by TradingView) As of the open this morning, FGEN is just 2% away from $40. A move under this support level could be coming soon. If that were to happen, a trader could enter a short position with the expectation that FGEN will have a breakdown. Want to Discover More Great Trades? I have explored virtually every flavor of technical analysis and chart pattern known to mankind. The sad fact is that the vast majority of them don\u2019t work at all. That is why I recently put together this special report to help investors focus on the only 5 chart patterns that matter\u2026the ones that lead to the most timely and profitable stock trades. Click below to get your copy now! 5 WINNING Stock Chart Patterns Have a good trading day! Good luck! Christian Tharp, CMT @cmtstockcoach FGEN shares were trading at $40.88 per share on Wednesday morning, down $0.86 (-2.06%). Year-to-date, FGEN has declined -4.69%, versus a 8.15% rise in the benchmark S&P 500 index during the same period."}]}